Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose
TCTR20210225002Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Feb 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of human insulin and glucose in hyperkalemia, sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Incidence of hypoglycemia after insulin and glucose treatment for hyperkalemia. Started Feb 2021; status: completed.
02
Drugs
human insulinglucose
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on TCTR20210225002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210225002.